KN
Knowles Corporation22.32
-0.17-0.76%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Energy ramp details, strong bookings.
Q&A offered fresh details on the specialty film line's ramp, with the $25M+ energy order hitting full stride by end-Q2 for mostly H2 revenue, alongside $50-65M total category sales in 2026 from broadening apps like fracking and railguns. Management grew more bullish on MSA microsolutions for new medtech, collecting NREs now for 2027 ramps. Book-to-bill held above 1.0 in PD amid strong Q4 shipments and January bookings; industrial shows fresh momentum. Production for energy is on track in South Carolina. Capacity strains loom for H2 if demand persists. Investors will eye execution on these ramps. Q&A largely affirmed prepared optimism.
Key Stats
Market Cap
1.92BP/E (TTM)
55.80Basic EPS (TTM)
0.40Dividend Yield
0%Recent Filings
8-K
COO gets performance PSUs
Knowles Corporation granted COO Daniel J. Giesecke 18,423 target PSUs worth $500,000 on February 17, 2026, tied to Cornell Dubilier unit's revenue and adjusted EBIT goals over 2026-2027. Vesting requires hitting annual thresholds (90% for 60% payout, up to 110% for 140%), with full certification post-period and continued employment. Change of control accelerates target payout. Retention hinges on CD performance.
10-K
FY2025 results
Knowles drove FY2025 revenues to $593.2M, up 7.2% y/y, with PD surging 9.6% to $328.9M on medtech/defense demand and pricing while MSA grew 4.3% to $264.3M via Syntiant metal cans and specialty audio, yet margins squeezed from mix and yields. Q4 momentum shone in PD's factory utilization and cost cuts, lifting Adjusted EBIT margins to 20.2%; gross margins hit 44.5% non-GAAP. Generated $114.4M adjusted free cash flow (19.3% of sales), repurchased $65M shares ($129M remains), and cut debt to $114M revolver. No 2026 guidance disclosed. Customer concentration risks loom large.
8-K
Q4 revenue beats guidance
10-Q
Q3 FY2025 results
Knowles posted Q3 revenues of $152.9M, up 7.3% y/y from $142.5M, with operating earnings climbing to $25.8M from $18.7M as gross margins expanded to 45.7% from 44.1% on higher volumes and cost cuts in Precision Devices, despite CD yield hiccups. Diluted EPS from continuing ops hit $0.21, verified against 87.3M shares. Cash sits at $92.5M with $176.3M total debt ($72.3M seller note due Nov 2025, $104M revolver to 2028); op cash YTD $66.8M yielded $50.0M FCF (derived). Share buybacks totaled $55.0M YTD. Yet IP disputes loom large.
8-K
Q3 revenue beats, Q4 growth eyed
Knowles reported Q3 continuing operations revenue of $152.9M, up 7% year-over-year, with non-GAAP diluted EPS of $0.33 and operating cash flow of $29.1M at guidance highs. Precision Devices surged 12% on demand; MedTech & Specialty Audio edged up 2%. Q4 guides $151-161M revenue, 9% YoY growth; shares repurchased, debt cut. Cash flow dipped yet stays robust.
IPO
Website
Employees
Sector
Industry
CTS
CTS Corporation
44.52+0.39
DSWL
Deswell Industries, Inc.
3.30+0.00
KOSS
Koss Corporation
4.51-0.05
MPTI
M-tron Industries, Inc.
52.65-0.72
MRAAF
Murata Manufacturing Inc.
20.76-0.94
PLXS
Plexus Corp.
154.12-5.60
SONO
Sonos, Inc.
18.24-0.09
SPRS
Surge Components, Inc.
3.25+0.09
TTMI
TTM Technologies, Inc.
67.63-4.42
VICR
Vicor Corporation
93.45-2.14